Clinical characteristics, treatment options, and prognosis of subcutaneous panniculitis-like T-cell lymphoma from the SEER database.
Population-level data clarifies diagnosis and prognosis of a rare, often-misdiagnosed T-cell lymphoma, filling a meaningful gap for specialist care.
This SEER database study provides rare population-level evidence on subcutaneous panniculitis-like T-cell lymphoma, an uncommon and often misdiagnosed entity with limited treatment guidance. The analysis fills a meaningful evidence gap for clinicians managing this rare lymphoma subtype.
What the study was
- Study design
- Population-based cohort study (SEER database)
- Population
- Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) patients in SEER
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Hematology (Amsterdam, Netherlands)
Why it surfaced
Rare T-cell lymphoma with limited literature; SEER-based evidence is valuable for guidance; watchlist dual match (hematologic malignancy + rare disease).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.